Literature DB >> 17388942

Investigation of the PARK10 gene in Parkinson disease.

Y J Li1, J Deng, G M Mayhew, J W Grimsley, X Huo, J M Vance.   

Abstract

Two recent association mapping studies in Parkinson disease (PD) reported three candidate genes for the PARK10 locus: EIF2B3 as a modifier of age-at-onset of PD (min P= 0.0004) and HIVEP3 as a PD risk gene (P < or = 0.006) (Oliveira et al. 2005); and LOC200008 (CDCP2) identified by the whole genome association (WGA) study of PD of Maraganore et al. (2005). However, evaluation of the on-line PD WGA results revealed two significant SNPs in HIVEP3 in the two datasets, Tier 1 and Tier 2, used by Maraganore et al. (P < or = 0.008 for Tier 1 and P=0.03 for Tier 2 dataset). Here, we revisited both the HIVEP3 and CDCP2 loci by examining 47 SNPs, mostly tagging, in an expanded PD family dataset (293 multiplex and 467 singleton families). A discordant sibpair (DSP) dataset (one DSP per family), with similar data structure as the WGA Tier 1 dataset, was also tested. We confirmed our and other previous negative findings for CDCP2. However, five significant SNPs in HIVEP3 (min P=0.004) were observed, although the two significant HIVEP3 SNPs from the PD WGA study were not significant in our datasets. Even though the sets of significant HIVEP3 markers differ between studies, these findings strongly support HIVEP3 as a candidate for PARK10. Further testing of HIVEP3 by other groups is encouraged.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388942     DOI: 10.1111/j.1469-1809.2007.00353.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  9 in total

1.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

2.  Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development.

Authors:  Katarzyna Lubecka; Kirsty Flower; Megan Beetch; Jay Qiu; Lucinda Kurzava; Hannah Buvala; Adam Ruhayel; Samer Gawrieh; Suthat Liangpunsakul; Tracy Gonzalez; George McCabe; Naga Chalasani; James M Flanagan; Barbara Stefanska
Journal:  Epigenetics       Date:  2018-07-30       Impact factor: 4.528

3.  A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6.

Authors:  Anna C Cummings; Stephen L Lee; Jacob L McCauley; Lan Jiang; Amy Crunk; Lynne L McFarland; Paul J Gallins; Denise Fuzzell; Clare Knebusch; Charles E Jackson; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Ann Hum Genet       Date:  2011-05       Impact factor: 1.670

4.  Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol.

Authors:  Zhifeng Zhou; Qiaoping Yuan; Deborah C Mash; David Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

5.  Fine-mapping and candidate gene investigation within the PARK10 locus.

Authors:  Kristoffer Haugarvoll; Mathias Toft; Lisa Skipper; Michael G Heckman; Julia E Crook; Alexandra Soto; Owen A Ross; Mary M Hulihan; Jennifer M Kachergus; Sigrid B Sando; Linda R White; Timothy Lynch; J Mark Gibson; Ryan J Uitti; Zbigniew K Wszolek; Jan O Aasly; Matthew J Farrer
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

Review 6.  Gene expression in the addicted brain.

Authors:  Zhifeng Zhou; Mary-Anne Enoch; David Goldman
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

7.  Cortical gene expression: prognostic value for seizure outcome following temporal lobectomy and amygdalohippocampectomy.

Authors:  Matthew J Gallek; Jesse Skoch; Tracy Ansay; Mandana Behbahani; David Mount; Ann Manziello; Marlys Witte; Michael Bernas; David M Labiner; Martin E Weinand
Journal:  Neurogenetics       Date:  2016-06-02       Impact factor: 2.660

Review 8.  Parkinson's disease mouse models in translational research.

Authors:  Paul M A Antony; Nico J Diederich; Rudi Balling
Journal:  Mamm Genome       Date:  2011-05-11       Impact factor: 2.957

9.  Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts.

Authors:  Javier Simón-Sánchez; Peter Heutink; Thomas Gasser
Journal:  Neurobiol Aging       Date:  2015-07-10       Impact factor: 4.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.